Brain Res 623, 299-302, (1993). Jansen, K. L., Faull, R. L., Storey, P., & Leslie, R. A. View abstract in PubMed Post navigationPreviousPrevious post:Rat liver and kidney contain high densities of sigma-1 and sigma-2 receptors: Characterization by ligand binding and photoaffinity labeling.NextNext post:Modification of the N-methyl-Daspartate response by antidepressant sigma receptor ligands.Related PostsAnavex Life Sciences Presents New Data Identifying Treatment Response Biomarkers in Alzheimer’s Disease Patients Treated with Investigational ANAVEX®2-73 at 2018 Alzheimer’s Association International Conference (AAIC)July 25, 2018Anavex Life Sciences Receives Approval To Initiate Phase 2b/3 Clinical Trial of ANAVEX®2-73 for the Treatment of Early Alzheimer’s DiseaseJuly 3, 2018The dual regulation of oxidative stress by SIGMA1 receptors in physiological or pathological conditionsApril 1, 2017Targeting M1 muscarinic and sigma-1 receptors in Alzheimer’s disease: Reversal of pathological hallmarks and associated cognitive dysfunction in McGill-R-Thy1-APP ratsMarch 30, 2017
Anavex Life Sciences Presents New Data Identifying Treatment Response Biomarkers in Alzheimer’s Disease Patients Treated with Investigational ANAVEX®2-73 at 2018 Alzheimer’s Association International Conference (AAIC)July 25, 2018
Anavex Life Sciences Receives Approval To Initiate Phase 2b/3 Clinical Trial of ANAVEX®2-73 for the Treatment of Early Alzheimer’s DiseaseJuly 3, 2018
The dual regulation of oxidative stress by SIGMA1 receptors in physiological or pathological conditionsApril 1, 2017
Targeting M1 muscarinic and sigma-1 receptors in Alzheimer’s disease: Reversal of pathological hallmarks and associated cognitive dysfunction in McGill-R-Thy1-APP ratsMarch 30, 2017
